BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25902414)

  • 41. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.
    Nair SK; Boczkowski D; Morse M; Cumming RI; Lyerly HK; Gilboa E
    Nat Biotechnol; 1998 Apr; 16(4):364-9. PubMed ID: 9555728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
    Ohta K; Yamaguchi Y; Shimizu K; Miyahara E; Toge T
    Anticancer Res; 2002; 22(5):2597-606. PubMed ID: 12529970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
    Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA
    Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient antitumor immunity in a murine colorectal cancer model induced by CEA RNA-electroporated B cells.
    Park MY; Kim HS; Woo SJ; Kim CH; Park JS; Sohn HJ; Kim HJ; Oh ST; Kim TG
    Eur J Immunol; 2008 Aug; 38(8):2106-17. PubMed ID: 18624349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA vaccine expressing repeated carcinoembryonic antigen (CEA)(625-667) induces strong immunity in mice.
    Li D; Hua S; Fan Y; Xu S; Duan X; Liu L; Che Y; Li S; Tan Y
    Immunol Lett; 2011 Mar; 135(1-2):124-8. PubMed ID: 21073899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A carcinoembryonic antigen polynucleotide vaccine for human clinical use.
    Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Pike J; Curiel DT
    Cancer Gene Ther; 1995 Mar; 2(1):33-8. PubMed ID: 7621253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine.
    Cusi MG; Del Vecchio MT; Terrosi C; Savellini GG; Di Genova G; La Placa M; Fallarino F; Moser C; Cardone C; Giorgi G; Francini G; Correale P
    J Immunol; 2005 Jun; 174(11):7210-6. PubMed ID: 15905566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen.
    Mizobata S; Tompkins K; Simpson JF; Shyr Y; Primus FJ
    Cancer Immunol Immunother; 2000 Aug; 49(6):285-95. PubMed ID: 10946810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine.
    Zhu MZ; Marshall J; Cole D; Schlom J; Tsang KY
    Clin Cancer Res; 2000 Jan; 6(1):24-33. PubMed ID: 10656428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.
    Huarte E; Sarobe P; Lu J; Casares N; Lasarte JJ; Dotor J; Ruiz M; Prieto J; Celis E; BorrĂ¡s-Cuesta F
    Clin Cancer Res; 2002 Jul; 8(7):2336-44. PubMed ID: 12114438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells.
    Matera L; Beltramo E; Martinuzzi E; Buttiglieri S
    Clin Exp Immunol; 2004 Aug; 137(2):320-8. PubMed ID: 15270849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responses.
    Parsons T; Spendlove I; Nirula R; Writer M; Carter G; Carr F; Durrant LG
    Vaccine; 2004 Sep; 22(25-26):3487-94. PubMed ID: 15308376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
    Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
    Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells.
    Aquino A; Prete SP; Greiner JW; Giuliani A; Graziani G; Turriziani M; De Filippi R; Masci G; Bonmassar E; De Vecchis L
    Clin Cancer Res; 1998 Oct; 4(10):2473-81. PubMed ID: 9796980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice.
    Luo Y; O'Hagan D; Zhou H; Singh M; Ulmer J; Reisfeld RA; James Primus F; Xiang R
    Vaccine; 2003 May; 21(17-18):1938-47. PubMed ID: 12706680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA vaccines, electroporation and their applications in cancer treatment.
    Lee SH; Danishmalik SN; Sin JI
    Hum Vaccin Immunother; 2015; 11(8):1889-900. PubMed ID: 25984993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CEA Plasmid as Therapeutic DNA Vaccination against Colorectal Cancer.
    Veisi Malekshahi Z; Hashemi Goradel N; Shakouri Khomartash M; Maleksabet A; Kadkhodazadeh M; Kardar GA; Negahdari B
    Iran J Immunol; 2019 Sep; 16(3):235-245. PubMed ID: 31552832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor.
    Beecham EJ; Ortiz-Pujols S; Junghans RP
    J Immunother; 2000; 23(3):332-43. PubMed ID: 10838662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.